A Maschke

A. Maschke, PhD, is a R&D manager, BASF

Articles by A Maschke

Development of Orally Disintegrating Tablets Based on a New Excipient

ByS Kruse,S Gebert ,K Meyer-Böhm,A Maschke,Karl Kolter

November 2nd 2008

The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.

Latest Updated Articles

Development of Orally Disintegrating Tablets Based on a New Excipient
Published: November 2nd 2008 | Updated:

A Maschke

Articles by A Maschke

Development of Orally Disintegrating Tablets Based on a New Excipient

Latest Updated Articles

Trending on Pharmaceutical Technology

Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt

Everything to Know About Pharmaceutical Tariffs in 2025

Challenges for the Global Manufacturing of Vaccines

Integrating Sustainability into the Core of Pharmaceutical Science

Outsourcing Partners Providing End-to-End Service